Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dae W. Jun"'
Autor:
Chi‐Yi Chen, Wan‐Long Chuang, Albert Qin, Wen‐Hua Zhang, Li‐Ying Zhu, Guo‐Qiang Zhang, Jyh‐Jou Chen, Ching‐Chu Lo, Xinmin Zhou, Xiaorong Mao, Jia Shang, Hsing‐Tao Kuo, Wen Xie, Chien‐Hung Chen, Gin‐Ho Lo, Dae W Jun, Shuangsuo Dang, Chan‐Yen Tsai, Ting‐Fang Wang, Hsin‐Hui Lai, Kuan‐Chiao Tseng, Yi‐Wen Huang, Pei‐Jer Chen
Publikováno v:
JGH Open, Vol 6, Iss 11, Pp 782-791 (2022)
Abstract Background and Aim Ropeginterferon alfa‐2b is a novel mono‐pegylated, extra‐long‐acting interferon. It is administered infrequently and showed good tolerability and clinical activity for the chronic hepatitis B or C treatment in our
Externí odkaz:
https://doaj.org/article/b7057a2e69a042f3b15c1e087a8e6413
Autor:
Byoung K. Jang, Wan-Long Chuang, Jee-Fu Huang, R. N. Chien, Kathryn Razavi-Shearer, Henry Lik-Yuen Chan, Homie Razavi, Han-Chieh Lin, Jia H. Kao, Wai-Kay Seto, Tsung H. Hu, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Dae W. Jun, Chris Estes, George Boon-Bee Goh, James Fung, Jin-Woo Lee
Publikováno v:
Alimentary Pharmacology & Therapeutics
Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) account for an increasing proportion of liver disease in the Asia-Pacific region. Many areas in the region are experiencing epidemics of metabolic syndrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912959a888dc32f6d4d3a10c77505fb4
http://europepmc.org/articles/PMC7154715
http://europepmc.org/articles/PMC7154715